Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duo An

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|November 22, 2019
Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulationQingsheng Liu, Alan Chiu, Long-Hai Wang, et al.
Nature Immunology|May 22, 2019
Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesityYewei Ji, Shengyi Sun, Neha Shrestha, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Nature Communications|November 22, 2019
Zwitterionically modified alginates mitigate cellular overgrowth for cell encapsulationQingsheng Liu, Alan Chiu, Long-Hai Wang, et al.
Nature Immunology|May 22, 2019
Toll-like receptors TLR2 and TLR4 block the replication of pancreatic β cells in diet-induced obesityYewei Ji, Shengyi Sun, Neha Shrestha, et al.
Nature|November 10, 2022
Non-viral precision T cell receptor replacement for personalized cell therapySusan P Foy, Kyle Jacoby, Daniela A Bota, et al.
Nature|March 8, 2023
Neoantigen-targeted CD8<sup>+</sup> T cell responses with PD-1 blockade therapyCristina Puig-Saus, Barbara Sennino, Songming Peng, et al.
Pageof 4